Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost
South Africa
Get Microdata
Reference ID
SafetyEffectivenessandImmunogenicityofheterologousmRNA-1273Boost
Producer(s)
Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Azwidhwi Takalani, Kubashni Woeber, Annie Bodenstein, Phumeza Jonas, Imke Engelbrecht, Waasila Jassat, Harry Moultrie, Debbie Bradshaw, Ishen Seocharan, Jackline Odhiambo, Kentse Khuto, Simone I. Richardson, Millicent A. Omondi, Rofhiwa Nesamari,
Metadata
Created on
Apr 29, 2024
Last modified
Apr 29, 2024
Page views
25419
Downloads
2
- Data files
- SHERPA_Safetydata
drug_name_anti_infla_v_2 (drug_name_anti_infla_v_2)
Data file: SHERPA_Safetydata
Overview
Valid:
67
Invalid:
0
Type:
Discrete
Width:
40
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| Amitryptilline | 1 |
1.5%
|
|
| Brufen | 6 |
9%
|
|
| CELECOXIB | 1 |
1.5%
|
|
| Celebrex | 1 |
1.5%
|
|
| Celecoxib | 1 |
1.5%
|
|
| DICLOFENAC | 1 |
1.5%
|
|
| Diclofenac | 4 |
6%
|
|
| Etoricoxib | 1 |
1.5%
|
|
| IBUPROFEN | 2 |
3%
|
|
| INDOMETHACIN | 1 |
1.5%
|
|
| Ibuprofen | 5 |
7.5%
|
|
| Ibuprufen | 1 |
1.5%
|
|
| Myogel | 1 |
1.5%
|
|
| Naproxin | 1 |
1.5%
|
|
| Nusac | 1 |
1.5%
|
|
| Painamol | 1 |
1.5%
|
|
| Panado | 5 |
7.5%
|
|
| Paracetamol | 4 |
6%
|
|
| Paracetamol PRN | 1 |
1.5%
|
|
| Plasmoquine | 1 |
1.5%
|
|
| SEFERIO 25/250 HFA | 1 |
1.5%
|
|
| SULFASALAZINE | 1 |
1.5%
|
|
| Stillpayn | 1 |
1.5%
|
|
| Stilpane | 1 |
1.5%
|
|
| Stilpayne | 1 |
1.5%
|
|
| Sulfasalazine | 1 |
1.5%
|
|
| Synoleve | 1 |
1.5%
|
|
| TRAMADOL | 3 |
4.5%
|
|
| Tramadol | 7 |
10.4%
|
|
| Tramadol 50mg po 8hrly (every +-2 weeks) | 1 |
1.5%
|
|
| Tramoltra | 1 |
1.5%
|
|
| amytriptilene | 1 |
1.5%
|
|
| diclofenac | 1 |
1.5%
|
|
| etoricoxib | 1 |
1.5%
|
|
| ibuprofen 400mg | 1 |
1.5%
|
|
| paracetamol | 1 |
1.5%
|
|
| tramadol | 2 |
3%
|
|
| voltaren | 1 |
1.5%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.